Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMS7INR)

• Drug Name: AZD-0902 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Chronic obstructive pulmonary disease	CA22	Terminated	[1]
Rheumatoid arthritis	FA20	Terminated	[1]

• Cross-matching ID: TTD Drug ID: DMS7INR

Molecule-Related Drug Atlas

Drug(s) Targeting Ion channel unspecific (IC)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
ATI-2042	DMWP59B	Atrial fibrillation	BC81.3	Phase 2	[3]
Lu-AA39959	DM34FWR	Bipolar disorder	6A60	Phase 2	[4]
AZD-2927	DM6AI9N	Atrial fibrillation	BC81.3	Phase 2	[5]
Lu-AA38466	DMGUX5Y	Neurological disorder	6B60	Discontinued in Phase 1	[6]

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Ion channel unspecific (IC)	TTM7WCE	NOUNIPROTAC	Antagonist	[2]

References

• [1] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800019129)
• [2] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800019129)
• [3] A randomized trial of budiodarone in paroxysmal atrial fibrillation. J Interv Card Electrophysiol. 2012 Jun;34(1):1-9.
• [4] Lundbeck: leading the way in the treatment of CNS disorders.
• [5] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7704).
• [6] Lundbeck is developing new and promising pharmaceuticals for the treatment of depression, anxiety and psychotic disorders and for new disease areas such as stroke and alcohol dependence. Pipeline report of Lundbeck in 2008.